AlphaCitation Enterprise
Evidence assurance for Medical, Regulatory and Market Access.
An annual fixed fee, scoped to your portfolio and markets. No metered usage, no overages.
Request a briefingBuilt for the enterprise, scaled for the team. It is scoped to your organisation before it runs, measured on a cadence you set, and set out for each team that acts on it.
- Portfolios and markets scoped to your organisation, not a plan limit
- Continuous measurement on an adaptive schedule, with change alerts
- Recurring briefings for leadership
- Regulated cases governed with a hashed, independently timestamped audit trail
- Team access across Commercial, Medical, Regulatory and Market Access
- Label changes turned into owned, approved work, closed only on a verified retest
Any assistant can run a query. You are paying for the measurement, and for the fix that follows it.
- The same method, every cycle. One versioned question design and decision rule across four engines, with every question asked recorded, so a change is a change in the engines, not in us.
- Decisions, not mentions. Whether your medicine is chosen, and over what, with the base stated.
- Checked against the record. Claims about a medicine’s approved uses and populations checked against the current label, dated, that governs the market: the FDA’s in the US, the EU product information of centrally authorised medicines in the EU and EEA, and both as benchmarks elsewhere.
- Provenance on every finding. Engine, model, time, question, full answer and returned sources behind each number.
- Change you can trust, a fix you can prove. Movement confirmed only beyond the noise band and across cycles; each fix given an owner and the review it needs, and its retest read against what you registered beforehand.
AlphaCitation Monitor
Track your own brands, and read the result yourself.
The same measurement, on a live dashboard, billed monthly. Regulated-claim verification and the case workflow are part of Enterprise.
| Capability | Basic$99/moOne brand, re-measured on a recurring schedule. | RecommendedGrowth$299/moA small portfolio, with trend and community intelligence. | Agency$599/moTen brands, reported under your own name. |
|---|---|---|---|
| Scope | |||
| Brands monitored | 1 | 3 | 10 |
| Questions per brand, per cycle | 60 | 60 | 60 |
| AI engines covered | 4 | 4 | 4 |
| Measurement | |||
| Adaptive sampling: questions added until each reading is precise enough to report | Included | Included | Included |
| 95% confidence intervals on measured rates | Included | Included | Included |
| Adaptive re-scan and drop alerts | Included | Included | Included |
| Longitudinal trend tracking | Not included | Included | Included |
| Forum and community sources | Not included | Included | Included |
| Whether AI crawlers can read your site | Not included | Included | Included |
| Reporting | |||
| Diagnosis and recommended actions | Included | Included | Included |
| Shareable scorecard | Included | Included | Included |
| Executive report export | Not included | Included | Included |
| Client-branded reporting | Not included | Not included | Included |
Subscriptions are billed monthly and renew until cancelled; you can cancel at any time. Every plan queries the developer APIs behind ChatGPT, Claude, Gemini and Perplexity. Checkout is operated and billed by Akunudo LLC-FZ, which owns and operates AlphaCitation, so that is the name that will appear at payment and on your statement. By subscribing you agree to our Terms, Privacy Policy and Refund Policy.